Business Standard

Alembic Pharmaceuticals standalone net profit rises 32.69% in the March 2016 quarter

Image

Capital Market

Sales rise 19.19% to Rs 587.35 crore

Net profit of Alembic Pharmaceuticals rose 32.69% to Rs 89.02 crore in the quarter ended March 2016 as against Rs 67.09 crore during the previous quarter ended March 2015. Sales rose 19.19% to Rs 587.35 crore in the quarter ended March 2016 as against Rs 492.79 crore during the previous quarter ended March 2015.

For the full year,net profit rose 143.58% to Rs 698.13 crore in the year ended March 2016 as against Rs 286.61 crore during the previous year ended March 2015. Sales rose 48.25% to Rs 2988.19 crore in the year ended March 2016 as against Rs 2015.70 crore during the previous year ended March 2015.

 
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales587.35492.79 19 2988.192015.70 48 OPM %23.7619.56 -32.8620.23 - PBDT141.3596.48 47 985.16407.27 142 PBT117.2485.52 37 913.30362.86 152 NP89.0267.09 33 698.13286.61 144

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 27 2016 | 4:52 PM IST

Explore News